We are live on ! Find out more
KB

Kimelman & Baird Portfolio holdings

AUM $1.22B
1-Year Est. Return 11.47%
This Fund
S&P 500
This Quarter Est. Return
+2.22%
1 Year Est. Return
+11.47%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$660M
AUM Growth
+$3.27M
Cap. Flow
-$5.55M
Cap. Flow %
-0.84%
Top 10 Hldgs %
37.72%
Holding
128
New
6
Increased
27
Reduced
22
Closed
7

Top Buys

Rank Stock Value
1
COST icon
Costco
COST
+$14.7M
2
XBI icon
State Street SPDR S&P Biotech ETF
XBI
+$5.15M
3
COP icon
ConocoPhillips
COP
+$4.54M
4
FTI icon
TechnipFMC
FTI
+$455K
5
MRK icon
Merck
MRK
+$354K

Top Sells

Rank Stock Value
1
CPRT icon
Copart
CPRT
+$16.6M
2
CMD
Cantel Medical Corporation
CMD
+$9.35M
3
LLY icon
Eli Lilly
LLY
+$2.25M
4
MJN
Mead Johnson Nutrition Company
MJN
+$1.34M
5
BMY icon
Bristol-Myers Squibb
BMY
+$490K

Sector Composition

Rank Sector Weight
1 Industrials 18.86%
2 Financials 14.21%
3 Healthcare 12.56%
4 Consumer Discretionary 12.5%
5 Communication Services 11.09%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
NUE icon
51
Nucor
NUE
$56.4B
$2.66M 0.4%
45,900
– –
PG icon
52
Procter & Gamble
PG
$343B
$2.51M 0.38%
28,800
– –
JNJ icon
53
Johnson & Johnson
JNJ
$635B
$2.23M 0.34%
16,867
– –
KMB icon
54
Kimberly-Clark
KMB
$36.4B
$2.15M 0.33%
16,690
– –
ABBV icon
55
AbbVie
ABBV
$458B
$2.06M 0.31%
28,400
-100
-0.4% -$6.72K
MMM icon
56
3M
MMM
$89B
$1.94M 0.29%
11,154
– –
CL icon
57
Colgate-Palmolive
CL
$72.6B
$1.65M 0.25%
22,300
– –
FDX icon
58
FedEx
FDX
$74.5B
$1.44M 0.22%
6,633
– –
KMI icon
59
Kinder Morgan
KMI
$73.1B
$1.23M 0.19%
64,000
– –
IP icon
60
International Paper
IP
$22.3B
$1.1M 0.17%
20,510
– –
ABT icon
61
Abbott
ABT
$180B
$1M 0.15%
20,570
– –
FNLC icon
62
First Bancorp
FNLC
$394M
$960K 0.15%
35,467
– –
WRI
63
DELISTED
Weingarten Realty Investors
WRI
$828K 0.13%
27,524
– –
QCOM icon
64
Qualcomm
QCOM
$176B
$803K 0.12%
14,549
-3,500
-19% -$196K
FMS icon
65
Fresenius Medical Care
FMS
$13.2B
$787K 0.12%
16,280
– –
FMC icon
66
FMC
FMC
$1.42B
$730K 0.11%
11,530
– –
ESRX
67
DELISTED
Express Scripts Holding Company
ESRX
$721K 0.11%
11,290
– –
UPS icon
68
United Parcel Service
UPS
$97.6B
$708K 0.11%
6,400
– –
GHDX
69
DELISTED
Genomic Health, Inc.
GHDX
$685K 0.1%
21,040
– –
PX
70
DELISTED
Praxair Inc
PX
$647K 0.1%
4,880
– –
KSU
71
DELISTED
Kansas City Southern
KSU
$628K 0.1%
6,000
-2,000
-25% -$188K
GRA
72
DELISTED
W.R. Grace & Co.
GRA
$625K 0.09%
8,680
– –
AMGN icon
73
Amgen
AMGN
$203B
$620K 0.09%
3,600
– –
TKR icon
74
Timken Company
TKR
$9.82B
$592K 0.09%
12,800
– –
APC
75
DELISTED
Anadarko Petroleum
APC
$569K 0.09%
12,558
– –
1 2
3
4 5

Similar funds

DPI
Diversified Portfolios Inc Bloomfield Hills, Michigan $1.22B AUM 11.83% 1-Year Est. Return
NPIC
Neumeier Poma Investment Counsel Carmel, California $1.21B AUM 70.48% 1-Year Est. Return
CS
Central Securities New York $1.21B AUM 19.91% 1-Year Est. Return
AG
Atairos Group Bryn Mawr, Pennsylvania $1.22B AUM 38.2% 1-Year Est. Return
TIM
Tortoise Investment Management White Plains, New York $1.21B AUM 13.04% 1-Year Est. Return
CCM
Coliseum Capital Management Rowayton, Connecticut $1.22B AUM 18.72% 1-Year Est. Return
GC
Gillson Capital Chicago, Illinois $1.22B AUM 7.54% 1-Year Est. Return
LWIC
Leith Wheeler Investment Counsel Vancouver, British Columbia, Canada $1.21B AUM 12.04% 1-Year Est. Return

Kimelman & Baird's Q2 2017 Portfolio in Review

As of Q2 2017, Kimelman & Baird held 128 positions worth $660M, up 0.5% from $657M the previous quarter. Its ten largest holdings account for 38% of the portfolio.

Kimelman & Baird's Q2 2017 filing shows 6 new, 27 increased, 22 reduced and 7 closed positions. Its largest new stake was State Street SPDR S&P Biotech ETF: 72,640 shares worth $5.61M. The largest sale was Copart, an estimated $16.6M.

By sector, the portfolio is most concentrated in Industrials at 19% of assets, down from 21% a quarter earlier, followed by Financials and Healthcare.

  • Kimelman & Baird's largest Q2 2017 buy was State Street SPDR S&P Biotech ETF: 72,640 shares worth $5.61M.
  • Kimelman & Baird added most to Costco in Q2 2017, an estimated $14.7M increase.
  • Kimelman & Baird's biggest Q2 2017 reduction was Copart, cutting an estimated $16.6M.
  • Kimelman & Baird fully exited Mead Johnson Nutrition Company in Q2 2017, selling an estimated $1.34M.
  • Kimelman & Baird's ten largest holdings make up 38% of its $660M portfolio in Q2 2017.
  • Kimelman & Baird opened 6 new positions and closed 7 in Q2 2017.
  • Kimelman & Baird's portfolio value rose 0.5% quarter-over-quarter to $660M.

Based on Kimelman & Baird's 13F filing for Q2 2017, filed 22 Aug 2017.